Journal of the Neurological Sciences
Volume 206, Issue 1 , Pages 91-95 , 15 January 2003

Low concentrations of glutamate induce apoptosis in cultured neurons: Implications for amyotrophic lateral sclerosis

  • Cristina Cid

      Affiliations

    • Servicio Bioquı́mica-Investigación, Hospital Ramón y Cajal, Ctra. Colmenar km 9.1, 28034 Madrid, Spain
    • ,
  • Jose C Alvarez-Cermeño

      Affiliations

    • Servicio Neurologı́a, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Ignacio Regidor

      Affiliations

    • Servicio Neurologı́a, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Matilde Salinas

      Affiliations

    • Servicio Bioquı́mica-Investigación, Hospital Ramón y Cajal, Ctra. Colmenar km 9.1, 28034 Madrid, Spain
    • ,
  • Alberto Alcazar

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +34-91-336-9016; fax: +34-91-336-9016.
    • Servicio Bioquı́mica-Investigación, Hospital Ramón y Cajal, Ctra. Colmenar km 9.1, 28034 Madrid, Spain

Received 10 May 2002 ,Accepted 28 August 2002.

References 

  1. Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch. Neurol. 2001;58:365–370
  2. Urushitani M, Shimohama S, Kihara T, Sawada H, Akaike A, Ibi M, et al.  Mechanisms of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann. Neurol. 1998;44:796–807
  3. Williams TL, Day NC, Ince PG, Kamboj RK, Shaw PJ. Calcium-permeable-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 1997;42:200–207
  4. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann. Neurol. 1990;28:3–8
  5. Lacomblez L, Bensimon G, Leigh N, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. ALS/riluzole study group II. Lancet. 1996;347:1427–1431
  6. Couratier Ph, Sindou Ph, Esclaire F, Louvel E, Hugon J. Neuroprotective effects of riluzole in ALS CSF toxicity. NeuroReport. 1994;5:1012–1014
  7. Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 1990;28:18–25
  8. Couratier Ph, Hugon J, Sindou Ph, Vallat JM, Dumas M. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet. 1993;341:265–268
  9. Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 1999;58:459–471
  10. Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, et al.  Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 2002;193:73–78
  11. Perry TL, Krieger C, Hansen S, Eisen A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann. Neurol. 1990;28:12–17
  12. Blin O, Samuel D, Nieoullon A, Serratice G. Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 1994;57:119–120
  13. Tikka TM, Vartiainen NE, Goldsteins G, Oja SS, Andersen PM, Marklund SL, et al.  Minoycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain. 2002;125:722–731
  14. Alcázar A, Regidor I, Masjuan J, Salinas M, Álvarez-Cermeño JC. Axonal damage induced by cerebrospinal fluid from patients with relapsing–remitting multiple sclerosis. J. Neuroimmunol. 2000;104:58–67
  15. Bottenstein JE, Sato GH. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. U. S. A. 1979;76:514–517
  16. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 1996;16:4069–4079
  17. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, et al.  Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335–339

PII: S0022-510X(02)00339-8

Journal of the Neurological Sciences
Volume 206, Issue 1 , Pages 91-95 , 15 January 2003

Article Tools

* Image Usage & Resolution